From digitization to digital operating models
After a decade of pilot purgatory, pharma boards are now asking a sharper question: which digital investments compound, and which decay? The answer is increasingly clear - programs anchored in a modern data backbone and a governed MES estate outperform isolated AI experiments by an order of magnitude.
Leaders are sequencing transformation around three pillars: an enterprise data platform, paperless GxP execution, and an AI factory aligned to clearly-owned business outcomes.
The new value pools
Predictive quality, intelligent scheduling and autonomous batch release are no longer aspirational. Vyana clients are routinely capturing 20–40% improvements in batch review time and 5–10 point gains in OEE within 18 months of program launch.
What to do in the next 90 days
Run a value-led maturity assessment, lock a North-Star architecture, and resequence the portfolio around outcomes - not technologies. Speed of value, not speed of deployment, is the new metric.
Senior practitioners at Vyana Healthcare specialising in pharma digital transformation, MES, SAP and AI-led operations.
